phenobarbital sodium molecular weight - An Overview
phenobarbital sodium molecular weight - An Overview
Blog Article
pentobarbital will lower the level or effect of bexarotene by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will decrease the level or effect of mavacamten by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Monitor Carefully (one)pentobarbital will decrease the level or effect of exemestane by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. For sufferers receiving exemestane with a powerful CYP3A4 inducer the recommended dose of exemestane is fifty mg day-to-day after a meal.
pentobarbital will lower the extent or effect of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Utilization of alternative solutions is strongly advised when linagliptin is usually to be administered with a CYP3A4 inducer
pentobarbital will minimize the extent or effect of stiripentol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. If unable to stay clear of coadministration of stiripentol with strong CYP3A4 inducers, improve stiripentol dose.
Workout caution when administered to people with acute or chronic ache; could cause paradoxical pleasure or crucial symptoms could possibly be masked
pentobarbital will minimize the level or effect of voriconazole by influencing hepatic enzyme CYP2C9/10 metabolism. Slight/Significance Not known.
pentobarbital will lower the level or effect of etravirine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Observe.
Contraindicated (one)pentobarbital decreases levels of vandetanib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Steer clear of coadministration with potent CYP3A4 inducers; these drugs minimize exposure to vandetanib by nearly 40%.
Corticosteroids: Barbiturates surface to boost the metabolism of exogenous corticosteroids most likely with the induction of hepatic microsomal enzymes. Sufferers stabilized on corticosteroid therapy may possibly require dosage adjustments if barbiturates are additional to or withdrawn from their dosage routine.
pentobarbital will click here reduce the extent or effect of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will reduce the level or effect of clarithromycin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unidentified.
pentobarbital and olopatadine intranasal both equally improve sedation. Stay clear of or Use Alternate Drug. Coadministration raises hazard of CNS despair, which can result in additive impairment of psychomotor performance and result in daytime impairment.
pentobarbital will reduce the level or effect of capivasertib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Sturdy or reasonable CYP3A inducers minimize capivasertib publicity, which may minimize efficacy.